Jeffrey G Meade, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2115 14th St, Suite 100, Auburn, NE 68305 Phone: 402-274-4993 Fax: 402-274-4905 |
Michael L Zaruba, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2115 14th Street, Suite 100, Auburn, NE 68305 Phone: 402-274-4993 Fax: 402-274-4905 |
Andrew Ensz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2115 14th St Ste 100, Auburn, NE 68305 Phone: 402-274-4993 Fax: 402-274-4905 |
Gary R Ensz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2115 14th St, Suite 100, Auburn, NE 68305 Phone: 402-274-4993 Fax: 402-274-4905 |
John A Gill, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2115 14th St Ste 100, Auburn, NE 68305 Phone: 402-274-4993 Fax: 402-274-4905 |
News Archive
Patients who had complex gynecologic surgery managed by an enhanced recovery pathway (ERP) resulted in decreased narcotic use, earlier discharge, stable readmission rates, excellent patient satisfaction and cost savings, according to a Mayo Clinic study. The findings are published in the journal Obstetrics & Gynecology.
While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal.
Two of the University of Minnesota Masonic Cancer Center's leading physician-scientists on research and treatment of cancers of the blood and bone marrow Philip McGlave, M.D., and Jeffrey Miller, M.D., have received renewed five-year program project research grants totaling almost $26 million from the National Cancer Institute (NCI).
Cerus Corporation announced today that investigators from blood centers in Sweden, Belgium, France and Slovenia will present their experience with the INTERCEPT Blood System for platelets and plasma during a leading international transfusion safety meeting, the XIIth International Haemovigilance Seminar taking place in Dubrovnik, Croatia from February 17 to 19.
In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially-matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms, and the need for a lifetime of pain medications and blood transfusions.
› Verified 3 days ago